Silexion Therapeutics Ltd.SLXNNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank42
Year-over-Year Change
Year-over-year operating income growth rate
Latest
-44.13%
↑ 97% vs avg
Percentile
P42
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-1351.71%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -44.13% |
| Q2 2025 | -38.42% |
| Q1 2025 | -6999.22% |
| Q4 2024 | 99.71% |
| Q3 2024 | -480.22% |
| Q2 2024 | -10.80% |
| Q1 2024 | 27.66% |
| Q4 2023 | -136.39% |
| Q3 2023 | -370.18% |
| Q2 2023 | -19141.58% |
| Q1 2023 | 99.83% |
| Q4 2022 | -105.95% |
| Q3 2022 | -50.96% |
| Q2 2022 | 55.17% |
| Q1 2022 | 19.19% |
| Q4 2021 | 0.00% |
| Q3 2021 | 100.00% |
| Q2 2021 | -110.53% |
| Q1 2021 | 52.69% |
| Q4 2020 | 0.00% |